[go: up one dir, main page]

UY35095A - HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN - Google Patents

HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN

Info

Publication number
UY35095A
UY35095A UY0001035095A UY35095A UY35095A UY 35095 A UY35095 A UY 35095A UY 0001035095 A UY0001035095 A UY 0001035095A UY 35095 A UY35095 A UY 35095A UY 35095 A UY35095 A UY 35095A
Authority
UY
Uruguay
Prior art keywords
compounds containing
containing nitrogen
heterocyclic compounds
present
compound
Prior art date
Application number
UY0001035095A
Other languages
Spanish (es)
Inventor
Taniguchi Takahiko
Sasaki Shigekazu
Nomura Izumi
Mikami Satoshi
Nakamura Shinji
Ashizawa Tomoko
Kawasaki Masanori
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2013/062140 external-priority patent/WO2013161913A1/en
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of UY35095A publication Critical patent/UY35095A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención provee un compuesto que tiene una acción inhibidora selectiva de la PDE2A, el cual es útil como agente para la profilaxis o tr atamiento de esquizofrenia, la enfermedad de Alzh eimer y similar. La presente invención es un compuesto representado por la fórmula (1): en donde c ada símbolo es como se describe en la memoria des criptiva, o una sal del mismo;The present invention provides a compound that has a selective inhibitory action of PDE2A, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzh eimer disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof;

UY0001035095A 2012-12-26 2013-10-23 HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN UY35095A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012283470 2012-12-26
PCT/JP2013/062140 WO2013161913A1 (en) 2012-04-25 2013-04-24 Nitrogenated heterocyclic compound

Publications (1)

Publication Number Publication Date
UY35095A true UY35095A (en) 2014-07-31

Family

ID=51453527

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035095A UY35095A (en) 2012-12-26 2013-10-23 HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN

Country Status (4)

Country Link
AR (1) AR093091A1 (en)
GE (1) GEP201606554B (en)
TW (1) TWI613200B (en)
UY (1) UY35095A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012004995A (en) * 2009-10-29 2012-10-03 Sirtris Pharmaceuticals Inc Bicyclic pyridines and analogs as sirtuin modulators.

Also Published As

Publication number Publication date
AR093091A1 (en) 2015-05-20
GEP201606554B (en) 2016-10-10
TW201427979A (en) 2014-07-16
TWI613200B (en) 2018-02-01

Similar Documents

Publication Publication Date Title
CR20140537A (en) NITROGEN HETEROCYCLIC COMPOUND
MX2013006113A (en) Bicyclic compound.
AR110381A2 (en) BIUTYL INHIBITORS OF TIROSINA CINASA DE BRUTON
NI201600058A (en) RING-FUSED BICYCLIC PYRIDYL-DERIVED COMPOUNDS AS FGFR4 INHIBITORS
CR20150078A (en) 1,4-DISPOSED PIRIDAZINE ANALOGS AND METHODS FOR THE TREATMENT OF CONDITIONS RELATED TO THE DEFICIENCY OF SMN
ECSP12011573A (en) TETRACYCLIC COMPOUNDS
CO6592104A2 (en) Heterocyclic compound
CL2015003491A1 (en) Chemical compounds.
ECSP14013329A (en) ARYLCARBONIL-4-OXY-PIPERIDINE COMPOUNDS USED FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
DOP2015000140A (en) HETEROCYCLIC COMPOUND
CL2020001752A1 (en) Derivative of oxy-fluoropiperidine as a kinase inhibitor.
DOP2019000193A (en) NEW HETEROCYCLIC COMPOUND, ITS PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
DOP2016000253A (en) NEW COMPOUNDS
GT201500247A (en) IMIDAZOPIRIDAZINAS REPLACED
CO2017010806A2 (en) Method for manufacturing novel compound containing nitrogen or salt thereof and manufacturing intermediate of the novel compound containing nitrogen or salt thereof
DOP2020000077A (en) NEW DERIVATIVE OF PHENYLPYRIDINE AND PHARMACEUTICAL COMPOSITION CONTAINING IT
DOP2016000251A (en) WNT SIGNALING ROAD INHIBITORS
BR112015016033A8 (en) pharmaceutical compositions for treating bacterial infections, and their uses
CL2019002025A1 (en) Pyrrolotriazine derivatives as a kinase inhibitor.
UY35095A (en) HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN
EA201501177A1 (en) PHARMACEUTICAL COMPOSITIONS
ECSP14026022A (en) NITROGENATED HETEROCYCLIC COMPOUND
AR125339A2 (en) NOTCH PATH SIGNALING INHIBITOR COMPOUND
AR084421A1 (en) BETAMETASONE AS AN ANTIBACTERIAL AGENT
UY35603A (en) HETEROCYCLIC COMPOUND

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210617